Id helix–loop–helix proteins inhibit nucleoprotein complex formation by the TCF ETS‐domain transcription factors

The Id subfamily of helix–loop–helix (HLH) proteins plays a fundamental role in the regulation of cellular proliferation and differentiation. Id proteins are thought to inhibit differentiation mainly through interaction with other HLH proteins and by blocking their DNA‐binding activity. Members of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The EMBO journal 1999-02, Vol.18 (4), p.968-976
Hauptverfasser: Yates, Paula R., Atherton, Graham T., Deed, Richard W., Norton, John D., Sharrocks, Andrew D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Id subfamily of helix–loop–helix (HLH) proteins plays a fundamental role in the regulation of cellular proliferation and differentiation. Id proteins are thought to inhibit differentiation mainly through interaction with other HLH proteins and by blocking their DNA‐binding activity. Members of the ternary complex factor (TCF) subfamily of ETS‐domain proteins have key functions in regulating immediate‐early gene expression in response to mitogenic stimulation. TCFs form DNA‐bound complexes with the serum response factor (SRF) and are direct targets of MAP kinase (MAPK) signal transduction cascades. In this study we demonstrate functional interactions between Id proteins and TCFs. Ids bind to the ETS DNA‐binding domain and disrupt the formation of DNA‐bound complexes between TCFs and SRF on the c‐ fos serum response element (SRE). Inhibition occurs by disrupting protein–DNA interactions with the TCF component of this complex. In vivo , the Id proteins cause down‐regulation of the transcriptional activity mediated by the TCFs and thereby block MAPK signalling to SREs. Therefore, our results demonstrate a novel facet of Id function in the coordination of mitogenic signalling and cell cycle entry.
ISSN:0261-4189
1460-2075
DOI:10.1093/emboj/18.4.968